Filing Flows › Comparisons › TDOC vs STLN
Teladoc Health vs Starling Oncology: TDOC and STLN compared
Teladoc Health is the larger company: $605M of revenue in its latest quarter (Q3 2026) against $170M for Starling Oncology (Q3 2026). Starling Oncology is growing faster (+24% against -3% a year earlier). Starling Oncology is more profitable, with an operating margin of -1.8% against -4.6%.
Where the money goes: TDOC and STLN
Teladoc Health (TDOC) · Q3 2026
Teladoc Health, Q3 2026: revenue $605M (-3% year over year), operating margin -4.6%, net loss $26.9M, operating cash flow $106M. The chart follows the revenue to costs, profit and cash.
Starling Oncology (STLN) · Q3 2026
Starling Oncology, Q3 2026: revenue $170M (+24% year over year), operating margin -1.8%, net loss $15.7M, operating cash flow $10.1M. The chart follows the revenue to costs, profit and cash.
| Teladoc Health (TDOC) | Starling Oncology (STLN) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $605M | $170M |
| Revenue growth, Y/Y | -3% | +24% |
| Operating margin | -4.6% | -1.8% |
| Net earnings | −$26.9M | −$15.7M |
| Net margin | -4.5% | -9.3% |
| Operating cash flow | $106M | $10.1M |
| Free cash flow | $105M | $8.9M |
| Market value | $1.6B | — |
| Analysts’ mean target | $8.58 | — |
Where the revenue comes from
Teladoc Health
- Access Fees: $467M (77%)
- Other: $138M (23%)
Starling Oncology
- Specialty Pharmacy: $109M (64%)
- Patient services: $60.0M (35%)
Questions
Which is bigger, Teladoc Health or Starling Oncology?
Teladoc Health is the larger company: $605M of revenue in its latest quarter (Q3 2026) against $170M for Starling Oncology (Q3 2026).
Is Teladoc Health or Starling Oncology growing faster?
Starling Oncology is growing faster (+24% against -3% a year earlier).
Which is more profitable, Teladoc Health or Starling Oncology?
Starling Oncology is more profitable, with an operating margin of -1.8% against -4.6%.
More: Teladoc Health earnings · how Teladoc Health makes money · Starling Oncology earnings · how Starling Oncology makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 29, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.